CYCLERION THERAPEUTICS, INC. Shareholders' Equity
CYCLERION THERAPEUTICS, INC. (CYCN) had Shareholders' Equity of $5.09 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $5.09M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $6.79M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $9.09M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.54M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $5.09M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $6.79M S-4/A · filed 2026-07-22 | |
| 2025-12-31 | $9.09M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $9.54M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $8.57M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $8.78M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $8.85M S-4/A · filed 2026-07-22 | |
| 2024-09-30 | $8.20M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $8.78M 10-Q · filed 2024-11-14 | |
| 2024-03-31 | $9.92M 10-Q · filed 2024-11-14 | |
| 2023-12-31 | $11.29M 10-K/A · filed 2025-11-12 | |
| 2023-09-30 | $12.87M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $5.15M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $3.92M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $10.45M 10-K · filed 2025-03-04 | |
| 2022-09-30 | $16.52M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $25.36M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $37.03M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $48.25M 10-K · filed 2024-03-05 | |
| 2021-09-30 | $56.39M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $65.22M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $48.43M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $59.49M 10-K · filed 2023-03-22 | |
| 2020-09-30 | $75.35M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $66.10M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $81.54M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $97.73M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $119.20M 10-Q · filed 2020-11-05 | $119.20M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $141.19M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | -$7.75M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | -$10.45M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$8.12M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$8.61M 10-Q · filed 2019-08-12 | |
| 2018-03-31 | -$4.75M 10-Q · filed 2019-05-13 | |
| 2017-12-31 | -$8.57M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |